首页> Oncogene> Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.

Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.

导出 LinkOut

翻译打印收藏纠错

第一作者： Z,Chen

第一单位： Department of Molecular Genetics and Microbiology, Shands Cancer Center, University of Florida, Gainesville, FL, USA.

作者： Z,Chen ^[1] ; J,Chen ^[2] ; Y,Gu ^[1] ; C,Hu ^[1] ; J-L,Li ^[3] ; S,Lin ^[1] ; H,Shen ^[4] ; C,Cao ^[5] ; R,Gao ^[5] ; J,Li ^[6] ; P K,Ha ^[7] ; F J,Kaye ^[5] ; J D,Griffin ^[2] ; L,Wu ^[1]

作者单位： Department of Molecular Genetics and Microbiology, Shands Cancer Center, University of Florida, Gainesville, FL, USA. ^[1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ^[2] Sanford-Burnham Medical Research Institute at Lake Nona, Orlando, FL, USA. ^[3] State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China. ^[4] Department of Medicine, Shands Cancer Center, University of Florida, Gainesville, FL, USA. ^[5] Teaching Hospital of Fujian Medical University, Fujian Province Tumor Hospital, Fuzhou, Fujian, China. ^[6] Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. ^[7]